Melanie Nicholson

Melanie Nicholson is an accomplished leader in global product strategy with extensive experience in the pharmaceutical industry. Currently serving as AVP of Global Product Strategy for the Immuno-Oncology Portfolio at Incyte since 2017, Melanie has successfully partnered with clinical development teams to guide late-stage pipeline strategies. Prior to Incyte, Melanie held various strategic leadership roles at Bristol-Myers Squibb, including Worldwide Commercial Lead for the Hematology Franchise and Executive Director positions in Commercialization Excellence and Product Commercialization. With a solid educational foundation in Business Administration and Marketing from Albright College and an MBA from the Philadelphia College of Textiles and Science, complemented by postgraduate studies in Graphic Design and executive leadership training at Rutgers University, Melanie demonstrates a well-rounded expertise in marketing and commercialization strategies across multiple therapeutic areas.